FDA Inspection 1249160 — Scott & White Medical Center- Temple Andrology Laboratory
The FDA completed an inspection of Scott & White Medical Center- Temple Andrology Laboratory on September 9, 2024 in Temple, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 9, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Temple, TX (United States)